GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visiomed Group (XPAR:ALVMG) » Definitions » Capex-to-Operating-Cash-Flow

Visiomed Group (XPAR:ALVMG) Capex-to-Operating-Cash-Flow : 0.96 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Visiomed Group Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Visiomed Group's Capital Expenditure for the six months ended in Dec. 2023 was €-1.20 Mil. Its Cash Flow from Operations for the six months ended in Dec. 2023 was €1.25 Mil.

Hence, Visiomed Group's Capex-to-Operating-Cash-Flow for the six months ended in Dec. 2023 was 0.96.


Visiomed Group Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Visiomed Group's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visiomed Group Capex-to-Operating-Cash-Flow Chart

Visiomed Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.35

Visiomed Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.96

Competitive Comparison of Visiomed Group's Capex-to-Operating-Cash-Flow

For the Medical Instruments & Supplies subindustry, Visiomed Group's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Visiomed Group's Capex-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visiomed Group's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Visiomed Group's Capex-to-Operating-Cash-Flow falls into.



Visiomed Group Capex-to-Operating-Cash-Flow Calculation

Visiomed Group's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-2.609) / 1.111
=2.35

Visiomed Group's Capex-to-Operating-Cash-Flow for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-1.197) / 1.25
=0.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Visiomed Group  (XPAR:ALVMG) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Visiomed Group Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Visiomed Group's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Visiomed Group (XPAR:ALVMG) Business Description

Traded in Other Exchanges
Address
8, Avenue Kléber, Paris, FRA, 75116
Visiomed Group is engaged in the development, designing, and marketing of medical products. The product portfolio includes various thermometers, natural mud, cold spray, connected activity bracelets, connected scales, inhalers, humidifiers, baby flies, natural wax, comfort foam, antibacterial solutions, baby nutrition, baby accessories, among others.

Visiomed Group (XPAR:ALVMG) Headlines

No Headlines